Navigation Links
CMC Limited and FileVision LLC Announce Partnership to Provide Business Productivity Solutions to a Global Market
Date:8/4/2009

ATLANTA, Aug. 4 /PRNewswire/ -- CMC Limited and FileVision LLC announced today their partnership to facilitate the delivery of enterprise content management (ECM) and business process automation (BPA) solutions to the global enterprise market. The direct relationship between FileVision's productivity software solution and CMC Ltd.'s world class consultancy services will help companies rapidly automate existing manual and document intensive processes, dramatically increasing knowledge worker productivity.

As more companies try to find areas to trim their budgets, the automation of processes is increasingly seen as a way to not only cut cost but improve accuracy. FileVision software offers a unique approach to content management. FileVision's innovative Information Relationship Manager (IRM) creates knowledge based relationships between people, data, assets and processes. Combined with FileVision's rapidly deployable BPA software, enterprise specific workflows can be created to automate the simple to extremely complex business processes.

According to Ramanathan Ramanan, CMC's Managing Director and Chief Executive Officer, "Our partnership with FileVision will provide CMC a strategic platform to expand our solution and services offering in the growing large scale digitization solutions and business process automation. When combined with CMC's extensive domain expertise, project management and technological competencies, the FileVision application suite will significantly enhance our robust client offerings."

Dave Jones, FileVision CEO stated that "We are excited about our partnership with such a world class IT consultancy enterprise as CMC Ltd. This partnership provides FileVision with an extended global reach and the ability to provide our existing enterprise customers with exceptional domain and project services."


'/>"/>
SOURCE FileVision
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. BMP Sunstone Divests Ownership Stake in Alliance BMP Limited
2. Limited data suggest possible association between Agent Orange exposure
3. Earlier HIV antiviral treatment can be cost effective in areas of limited resources
4. Organ Transplant Waiting Lists Not Limited to In-State Residents...Steve Jobs Liver Transplant Showcases Travel Option for Organ Transplant
5. Alere Introduces Industrys First 12-month Unlimited Health Coaching Program
6. Cooper Martin Unveils Innovative, Stylish Recovery Clothing for Those with Limited Mobility
7. K-State Researchers and Their Partners Making it Easier for Rural Kansans of All Ages to Stay Healthy Despite Limited Access to Facilities Like Bike Trails, Gyms
8. Accumetrics, Inc. Announces United Kingdom Distribution Agreement With ELITech UK Limited
9. The Female Health Company / HLL Lifecare Limited Receive National AIDS Control Organization of India Order for 1.5 Million FC2 Female Condoms
10. Helen of Troy Limited Announces Closing of Global Infusium Brand Acquisition From Procter & Gamble
11. Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Mercy Gynecologic Oncologist Dr. Dwight Im Receives “Patients' Choice” Award 2Health News:ThermoGenesis Corp. Names Healthcare Industry Executive Craig Moore to Board of Directors 2Health News:ThermoGenesis Corp. Names Healthcare Industry Executive Craig Moore to Board of Directors 3Health News:ThermoGenesis Corp. Names Healthcare Industry Executive Craig Moore to Board of Directors 4Health News:Discovery Health's New Year, New You Week Brings Transformation and Inspiration to the Resolution Season 2Health News:Discovery Health's New Year, New You Week Brings Transformation and Inspiration to the Resolution Season 3Health News:Discovery Health's New Year, New You Week Brings Transformation and Inspiration to the Resolution Season 4Health News:Consumer Watchdog Releases Coercive Lobbying E-Mail to Employees of United Health Group, Calls It 'Political Harassment' of Workers 2Health News:Consumer Watchdog Releases Coercive Lobbying E-Mail to Employees of United Health Group, Calls It 'Political Harassment' of Workers 3Health News:Consumer Watchdog Releases Coercive Lobbying E-Mail to Employees of United Health Group, Calls It 'Political Harassment' of Workers 4Health News:Jefferson neurosurgeon helps draft new treatment guidelines for brain metastases 2
Breaking Medicine Technology:Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Ohio Nurses Association Announces New President 3B 2009 2011 Board of Directors 61172 1Ohio Nurses Association Announces New President 3B 2009 2011 Board of Directors 61172 2Ingenious Med Partners with Childrens Restoration Network for Holiday Charity 61170 1Ingenious Med Partners with Childrens Restoration Network for Holiday Charity 61170 2Cellerix Raises EUR27 Million in a First Closing 14796 1Cellerix Raises EUR27 Million in a First Closing 14796 2